Fidson Healthcare Plc (NGX:FIDSON)
Nigeria · Delayed Price · Currency is NGN 40.00
0.00 (0.00%)
At close: Nov 18, 2025
Fidson Healthcare Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 10,313 | 5,779 | 3,608 | 4,187 | 3,720 | 1,205 | Upgrade |
Depreciation & Amortization | 2,077 | 1,668 | 1,267 | 985.88 | 801.24 | 814.03 | Upgrade |
Loss (Gain) From Sale of Assets | -2.38 | -0.91 | -8.29 | -34.23 | -83.26 | -8.79 | Upgrade |
Provision & Write-off of Bad Debts | 301.44 | 301.44 | 227.78 | -45.85 | 245.05 | 276.03 | Upgrade |
Other Operating Activities | 13,161 | 5,916 | 1,903 | 1,211 | 1,576 | 1,934 | Upgrade |
Change in Accounts Receivable | -7,081 | -621.83 | -1,866 | -1,224 | -248.6 | 532.44 | Upgrade |
Change in Inventory | 4,700 | -7,825 | -1,750 | -3,452 | -4,291 | -3,405 | Upgrade |
Change in Accounts Payable | -4,303 | 1,295 | 2,060 | 2,569 | 2,270 | 914.28 | Upgrade |
Change in Unearned Revenue | - | - | - | - | -165.06 | 814.6 | Upgrade |
Change in Other Net Operating Assets | 1,698 | -7,017 | -3,893 | -456.17 | 1,056 | -193.84 | Upgrade |
Operating Cash Flow | 20,864 | -505.29 | 1,548 | 3,740 | 4,880 | 2,882 | Upgrade |
Operating Cash Flow Growth | - | - | -58.62% | -23.36% | 69.34% | - | Upgrade |
Capital Expenditures | -5,882 | -3,693 | -4,446 | -6,614 | -2,646 | -1,985 | Upgrade |
Sale of Property, Plant & Equipment | 9.68 | 2.97 | 17.38 | 1,182 | 570.17 | 21.36 | Upgrade |
Sale (Purchase) of Intangibles | -749.49 | -175.49 | -83.92 | -57.35 | -38.55 | -33.56 | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | - | - | -86.3 | Upgrade |
Investment in Securities | - | - | - | - | - | 272.03 | Upgrade |
Other Investing Activities | 107.32 | 44.95 | 19.7 | 63.38 | 36.82 | 5.86 | Upgrade |
Investing Cash Flow | -6,515 | -3,821 | -4,492 | -5,425 | -2,078 | -1,805 | Upgrade |
Short-Term Debt Issued | - | 15,647 | 10,000 | 850 | - | - | Upgrade |
Long-Term Debt Issued | - | 8,300 | 11,105 | 5,707 | 3,500 | 6,768 | Upgrade |
Total Debt Issued | 39,573 | 23,947 | 21,105 | 6,557 | 3,500 | 6,768 | Upgrade |
Short-Term Debt Repaid | - | -10,000 | -3,000 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -9,686 | -3,662 | -2,020 | -5,886 | -2,673 | Upgrade |
Total Debt Repaid | -35,706 | -19,686 | -6,662 | -2,020 | -5,886 | -2,673 | Upgrade |
Net Debt Issued (Repaid) | 3,867 | 4,261 | 14,443 | 4,537 | -2,386 | 4,095 | Upgrade |
Common Dividends Paid | -2,965 | -1,377 | -1,270 | -1,043 | -512.59 | -312.94 | Upgrade |
Other Financing Activities | -7,017 | -4,916 | -2,049 | -1,680 | -1,173 | -1,334 | Upgrade |
Financing Cash Flow | -6,114 | -2,031 | 11,124 | 1,814 | -4,071 | 2,448 | Upgrade |
Foreign Exchange Rate Adjustments | -1,243 | - | - | - | -8.04 | -309.35 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 2,270 | -0 | Upgrade |
Net Cash Flow | 6,992 | -6,357 | 8,180 | 128.64 | 992.93 | 3,216 | Upgrade |
Free Cash Flow | 14,982 | -4,198 | -2,898 | -2,873 | 2,234 | 897.42 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 148.96% | - | Upgrade |
Free Cash Flow Margin | 12.75% | -4.99% | -5.46% | -7.07% | 7.24% | 4.91% | Upgrade |
Free Cash Flow Per Share | 6.52 | -1.83 | -1.26 | -1.25 | 0.97 | 0.39 | Upgrade |
Cash Interest Paid | 7,017 | 4,949 | 2,049 | 1,700 | 1,222 | 1,334 | Upgrade |
Cash Income Tax Paid | 2,349 | 839.09 | 1,396 | 1,375 | 116.04 | 95.47 | Upgrade |
Levered Free Cash Flow | 3,723 | -6,051 | -4,535 | -4,246 | -1,061 | -2,150 | Upgrade |
Unlevered Free Cash Flow | 8,053 | -2,617 | -3,221 | -3,138 | -297.33 | -1,317 | Upgrade |
Change in Working Capital | -4,986 | -14,169 | -5,449 | -2,563 | -1,379 | -1,338 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.